LORI M HENDERSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LORI M HENDERSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LORI M HENDERSON. LORI M HENDERSON is SVP, Secretary & Gen Counsel in ALBANY MOLECULAR RESEARCH INC ($AMRI) and SVP, Secretary & Gen. Counsel in ALBANY MOLECULAR RESEARCH INC ($AMRI) and Vice President in MOLDFLOW CORP ($MFLO) and General Counsel and Secretary in Moderna, Inc. ($MRNA).
Latest Insider Trading Transactions of LORI M HENDERSON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRI, MRNA, MFLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 93,476 | |
May 07 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 147.82 | 6,600 | 975,612 | 901 | 7.5 K to 901 (-87.99 %) |
May 07 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
May 06 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 100,076 | |
May 06 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 185.25 | 6,600 | 1,222,650 | 901 | 7.5 K to 901 (-87.99 %) |
May 06 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 106,676 | |
Apr 30 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 182.49 | 6,600 | 1,204,434 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 30 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 29 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 113,276 | |
Apr 29 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 178.29 | 6,600 | 1,176,714 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 29 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 119,876 | |
Apr 23 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 168.26 | 6,600 | 1,110,516 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 23 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 22 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 126,476 | |
Apr 22 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 160.32 | 6,600 | 1,058,112 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 22 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 139,676 | |
Apr 14 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 146.62 | 6,600 | 967,692 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 14 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 146,276 | |
Apr 09 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 132.85 | 6,600 | 876,810 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 09 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 08 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 152,876 | |
Apr 08 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 130.01 | 6,600 | 858,066 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 08 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 159,476 | |
Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 132.51 | 6,600 | 874,566 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 166,076 | |
Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 123.30 | 6,600 | 813,780 | 901 | 7.5 K to 901 (-87.99 %) |
Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 172,676 | |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 126.88 | 6,600 | 837,408 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 26 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 216 | 4,521 | 185,876 | |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,384 | 165,537 | 118,155 | |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 144.39 | 6,600 | 952,974 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 216 | 4,521 | 7,501 | 7.3 K to 7.5 K (+2.96 %) |
Mar 19 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,384 | 165,537 | 7,285 | 901 to 7.3 K (+708.55 %) |
Mar 18 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 124,539 | |
Mar 18 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 148.50 | 6,600 | 980,100 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 18 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 131,139 | |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 133.29 | 6,600 | 879,714 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 137,739 | |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 127.11 | 6,600 | 838,926 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 144,339 | |
Mar 05 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 128.58 | 6,600 | 848,628 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 05 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 150,939 | |
Mar 04 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 153.77 | 6,600 | 1,014,882 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 04 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Oct 23 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 14.85 | 32,000 | 475,200 | 367,522 | |
Oct 23 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 71.39 | 700 | 49,973 | 681 | 1.4 K to 681 (-50.69 %) |
Oct 23 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 70.56 | 15,455 | 1,090,505 | 1,381 | 16.8 K to 1.4 K (-91.80 %) |
Oct 23 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 69.84 | 14,148 | 988,096 | 16,836 | 31 K to 16.8 K (-45.66 %) |
Oct 23 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 68.70 | 1,697 | 116,584 | 30,984 | 32.7 K to 31 K (-5.19 %) |
Oct 23 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 14.85 | 32,000 | 475,200 | 32,681 | 681 to 32.7 K (+4,698.97 %) |
Jun 19 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 14.85 | 64,000 | 950,400 | 399,522 | |
Jun 19 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 63.03 | 64,000 | 4,033,920 | 681 | 64.7 K to 681 (-98.95 %) |
Jun 19 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 14.85 | 64,000 | 950,400 | 64,681 | 681 to 64.7 K (+9,397.94 %) |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 14.85 | 64,000 | 950,400 | 463,522 | |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 70.00 | 64,000 | 4,480,000 | 0 | 64 K to 0 (-100.00 %) |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 14.85 | 64,000 | 950,400 | 64,000 | 0 to 64 K |
Mar 03 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | A | 25.93 | 157,539 | 4,084,986 | 157,539 | |
Mar 11 2019 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | A | 20.93 | 186,092 | 3,894,906 | 186,092 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 18.41 | 44,251 | 814,661 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 15.77 | 29,066 | 458,371 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 17.05 | 22,893 | 390,326 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 10.43 | 29,167 | 304,212 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 4,375 | 26,206 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 4,375 | 26,206 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 17,500 | 104,825 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.99 | 4,375 | 26,206 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 2.93 | 17,500 | 51,275 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 2.93 | 4,375 | 12,819 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 2.93 | 4,375 | 12,819 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 5.25 | 17,500 | 91,875 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | D | 4.87 | 50,000 | 243,500 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Sell | D | 21.75 | 66,717 | 1,451,095 | 0 | 66.7 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 0.00 | 4,722 | 0 | 66,717 | 62 K to 66.7 K (+7.62 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Gift | G | 0.00 | 9,857 | 0 | 52,138 | 62 K to 52.1 K (-15.90 %) |
Mar 06 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 14.52 | 432 | 6,273 | 61,995 | 62.4 K to 62 K (-0.69 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | A | 18.41 | 44,251 | 814,661 | 44,251 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 0.00 | 6,747 | 0 | 62,427 | 55.7 K to 62.4 K (+12.12 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 0.00 | 8,990 | 0 | 55,680 | 46.7 K to 55.7 K (+19.25 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 18.52 | 504 | 9,334 | 46,690 | 47.2 K to 46.7 K (-1.07 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 18.52 | 674 | 12,482 | 47,194 | 47.9 K to 47.2 K (-1.41 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 18.52 | 2,363 | 43,763 | 47,868 | 50.2 K to 47.9 K (-4.70 %) |
Feb 01 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 18.11 | 553 | 10,015 | 50,231 | 50.8 K to 50.2 K (-1.09 %) |
Feb 01 2017 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 18.11 | 553 | 10,015 | 50,784 | 51.3 K to 50.8 K (-1.08 %) |
Nov 17 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Sell | S | 17.00 | 6,000 | 102,000 | 51,337 | 57.3 K to 51.3 K (-10.46 %) |
Nov 03 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 15.09 | 409 | 6,172 | 57,337 | 57.7 K to 57.3 K (-0.71 %) |
Mar 04 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 15.33 | 421 | 6,454 | 57,746 | 58.2 K to 57.7 K (-0.72 %) |
Feb 19 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Sell | D | 0.00 | 1,459 | 0 | 58,167 | 59.6 K to 58.2 K (-2.45 %) |
Feb 19 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 15.37 | 463 | 7,116 | 59,626 | 60.1 K to 59.6 K (-0.77 %) |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Option Exercise | A | 15.77 | 29,066 | 458,371 | 29,066 | |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Grant | A | 15.77 | 12,682 | 199,995 | 60,089 | 47.4 K to 60.1 K (+26.75 %) |
Feb 05 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 16.16 | 684 | 11,053 | 47,407 | 48.1 K to 47.4 K (-1.42 %) |
Feb 01 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 15.97 | 554 | 8,847 | 48,091 | 48.6 K to 48.1 K (-1.14 %) |
Feb 01 2016 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M. | SVP, Secretary & Ge ... | Payment of Exercise | F | 15.97 | 554 | 8,847 | 48,645 | 49.2 K to 48.6 K (-1.13 %) |
Nov 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Grant | A | 19.16 | 5,000 | 95,800 | 49,199 | 44.2 K to 49.2 K (+11.31 %) |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Sell | D | 0.00 | 1,459 | 0 | 44,199 | 45.7 K to 44.2 K (-3.20 %) |
Jun 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Payment of Exercise | F | 0.00 | 476 | 0 | 45,658 | 46.1 K to 45.7 K (-1.03 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Option Exercise | A | 17.05 | 22,893 | 390,326 | 22,893 | |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | HENDERSON LORI M | SVP, Secretary & Ge ... | Grant | A | 17.05 | 10,588 | 180,525 | 46,134 | 35.5 K to 46.1 K (+29.79 %) |
Sep 04 2003 | MFLO | MOLDFLOW CORP | HENDERSON LORI M | Vice President | Option Exercise | M | 1.20 | 1,562 | 1,874 | 1,563 | |
Sep 04 2003 | MFLO | MOLDFLOW CORP | HENDERSON LORI M | Vice President | Buy | M | 1.20 | 1,562 | 1,874 | 2,239 | 677 to 2.2 K (+230.72 %) |
Page: 1